Yves Gonnissen active positions
| Companies | Position | Start | End |
|---|---|---|---|
SEPS Pharma NV
 SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | Director/Board Member | 2011-05-19 | - |
| Chief Executive Officer | 2007-10-18 | - | |
| Founder | 2007-10-18 | - | |
Amatsigroup SAS
 Amatsigroup SAS BiotechnologyHealth Technology Amatsigroup SASU provides human and veterinary drug development services. It offers bio services, pharmaceutical analysis solutions, formulation development, and manufacturing and clinical trial supply packaging and logistics. The company was founded on October 12, 2010 and is headquartered in Fontenilles, France. | Chairman | 2018-06-28 | - |
Eurofins Amatsigroup NV
 Eurofins Amatsigroup NV BiotechnologyHealth Technology Part of Eurofins Scientific SE, Eurofins Amatsigroup NV engages in the development of biological drugs. The company is based in Ghent, Belgium. The Belgian company was founded in 2007. The CEO is Yves Gonnissen. | Director/Board Member | 2015-01-14 | - |
| Chief Executive Officer | 2017-06-29 | - |
Career history of Yves Gonnissen
Former positions of Yves Gonnissen
| Companies | Position | Start | End |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Training of Yves Gonnissen
| Ghent University | Doctorate Degree |
| Université Catholique de Louvain | Graduate Degree |
Statistics
International
| Belgium | 5 |
| United States | 3 |
| France | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Private companies | 4 |
|---|---|
SEPS Pharma NV
SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Amatsigroup SAS
Amatsigroup SAS BiotechnologyHealth Technology Amatsigroup SASU provides human and veterinary drug development services. It offers bio services, pharmaceutical analysis solutions, formulation development, and manufacturing and clinical trial supply packaging and logistics. The company was founded on October 12, 2010 and is headquartered in Fontenilles, France. | Health Technology |
Eurofins Amatsigroup NV
Eurofins Amatsigroup NV BiotechnologyHealth Technology Part of Eurofins Scientific SE, Eurofins Amatsigroup NV engages in the development of biological drugs. The company is based in Ghent, Belgium. The Belgian company was founded in 2007. The CEO is Yves Gonnissen. | Health Technology |
- Stock Market
- Insiders
- Yves Gonnissen
- Experience
